Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Venous Thromboembolism 4Neoplasms 3Venous Thrombosis 2Thrombosis 1Pulmonary Embolism 1Lung Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Tinzaparin × Clear all
NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT00981903 2017-07-06

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

University of Southern California

Phase 2 Terminated
131 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡